Abbey Thomas
Mr. Ippolito
AP Biology / Current Event
9 March 2018
Murphy, Heather. “They're Hosting Parasitic Worms in Their Bodies to Help Treat a Neglected Disease.”
The New York Times, The New York Times, 1 Mar. 2018, www.nytimes.com/2018/03/01/health/parasitic-worms-schistosomiasis-trial.html?rref=collection%2Fcolumn%2Ftrilobites.
For this week’s current event, I reviewed Heather Murphy’s article entitled “They’re Hosting Parasitic Worms in Their Bodies to Help Treat a Neglected Disease”. The article focuses on the research done by a Norwegian infectious disease physician at Leiden University Medical Center, named Meta Roestenberg. She is studying schistosomiasis, and infectious disease that affects more than 200 million people, and killing thousands, and is primarily found in Sub-Saharan Africa. Schistosomiasis is caused by larvae that live in the shells on freshwater snails, that when inside the human body, will reproduce and cause chronic pain, fever, organ failure, internal bleeding, or genital infections that increase the chance of being infected by HIV. Roestenberg give students male parasites that cause the disease, and they are small so no reproduction happens, and the students are being treated with different drugs in hopes of finding one that could kill the parasites. So far her work has been successful, but there still are doctors that question how effective the drugs will be. One researcher, named Daniel Colley from the University of Georgia, said “that the drug is “not terribly effective” and given that the worms’ life span is five to 10 years, “That is a long time to have something as ugly as a schistosome living in your blood vessels, putting out excrement and things,’”. But many other researchers agree that the testing is unorthodox, but are willing to try it so that a vaccine can be found.
If Roestenberg research is success it will save the lives of thousands of people in Sub-Saharan Africa. Roestenberg’s need for “challenge trial” also highlights a problem within the medical community. Since this disease is not usually found outside of Africa, many large research groups stationed in the US and Europe are not looking for a vaccine since it does not affect them directly. Along with these issues, the lack of vaccine for Schistosomiasis is also due to lack of funding because companies do not want to invest in vaccines if they do not know if it will be effective on people. The problem with these claims is that it requires money to do trials to see if it is effective on humans, and so the production of vaccines like Schistosomiasis is put on stand still.
Overall, Murphy’s article on the research being done for Schistosomiasis disease was very well done and researched. One thing that Murphey did well during her article was explain why Dr. Roestenberg needed to do a challenge trial to find a vaccine, and this information helped the reader understand why the drastic tests were being done. One of her article’s weakness was that she quoted sources, but since she did not include their position in the infectious disease field, it was hard to know if they actually knew about this disease of were outsiders. She could strengthen this weakness by including how these researchers related to the topic.